1. Aguilera MI, Diaz Oliva SE, Escobedo AA, et al. Helicobacter pylori infection in children. BMJ Paed Open 2020; 4: e000679.
2.
Yuan C, Adeloye D, Luk TT, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lan Child Adol Health 2022; 6: 185-91.
3.
Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Alim Pharm Ther 2018; 47: 868-76.
4.
Tran V, Saad T, Tesfaye M, et al. Helicobacter pylori (H. pylori) risk factor analysis and prevalence prediction: a machine learning-based approach. BMC Inf Dis 2022; 22: 655.
5.
Ortiz-Princz D, Daoud G, Salgado-Sabel A, Cavazza ME. Helicobacter pylori infection in children: should it be carefully assessed? Eur Rev Med Pharm Sci 2016; 20: 1798-813.
6.
James KYH, Wan YL, Wee KN, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 2017; 153: 420-9.
7.
Ito M, Sugiyama A, Mino M, et al. Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study. J Gastr 2022; 57: 540-6.
8.
Miller AK, Williams SM. Helicobacter pylori infection causes both protective and deleterious effects in human health and disease. Genes Immun 2021; 22: 218-26.
9.
Lee YC, Maria PD, Graham DY. Diagnosis and treatment of Helicobacter pylori infection. Ann Rev Med 2022; 73: 183-93.
10.
Zhaksylyk A, Nurbakyt A, Grjibovski A, et al. Epidemiology of gastrointestinal disease among children and adolescents in Kazakhstan: 2012-2019. Open Acc Maced J Med Sci 2021; 9: 1244-9.
11.
Mežmale L, Polaka I, Rudzite D, et al. Prevalence and potential risk factors of Helicobacter pylori infection among asymptomatic individuals in Kazakhstan. Asian Pac J Can Prev 2021; 22: 597-602.
12.
Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastr 2019; 25: 4870-84.
13.
Mehrabani S. Helicobacter pylori infection in children: a comprehensive review. J Clin Med Maed 2019; 14: 292-7.
14.
Liu DS, Wang YH, Zhu ZH, et al. Characteristics of Helicobacter pylori antibiotic resistance: data from four different populations. Anti Res Inf Cont 2019; 8: 192.
15.
Savoldi A, Carrara E, Graham DY, et al. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology 2018; 155: 1372-82.
16.
Tacconelli E, Carrara E, Savoldi A. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lan Inf Dis 2018; 18: 318-27.
17.
Uehara N, Yagihashi A, Kondoh K, et al. Human-defensin-2 induction in Helicobacter Hp-infected gastric mucosal tissues: antimicrobial effect of overexpression. J Med Microb 2003; 52: 41-5.
18.
Pero R, Angrisano T, Brancaccio M, et al. Beta-defensins and analogs in Helicobacter pylori infections: mRNA expression levels, DNA methylation, and antibacterial activity. PLoS One 2019; 14: e0222295.
19.
Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1.25-dihydroxyvitamin D3. FASEB J 2005; 19: 1067-77.
20.
Hu W, Zhang L, Li MX. Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cells. Autophagy 2019; 15: 707-25.
21.
Wanibuchi K, Hosoda K, Ihara M, et al. Indene compounds synthetically derived from Vitamin D have selective antibacterial action on Helicobacter pylori. Lipids 2018; 53: 393-401.
22.
Assaad S, Costanian C, Jaffal L, et al. Association of TLR4 polymorphisms, expression, and vitamin D with Helicobacter pylori infection. J Pers Med 2019; 9: 2.
23.
Assaad S, Chaaban R, Tannous F, Costanian C. Dietary habits and Helicobacter pylori infection: a cross sectional study at a Lebanese hospital. BMC Gastr 2018; 18: 48.
24.
Han C, Ni Z, Yuan T. Influence of serum vitamin D level on Helicobacter pylori eradication: a multi-center, observational, prospective and cohort study. J Diges Dis 2019; 20: 421-6.
25.
Gao T, Zhao M, Zhang C, et al. Association of Helicobacter pylori infection with vitamin D deficiency in infants and toddlers. Amer J Trop Med Hyg 2020; 102: 541-6.
26.
Chen LW, Chien CY, Hsieh CW, et al. The associations between Helicobacter pylori infection, serum vitamin D, and metabolic syndrome: a community-based study. Medicine 2016; 95: e3616.
27.
Ikezaki H, Furusyo N, Jacques PF, et al. Higher dietary cholesterol and -3 fatty acid intakes are associated with a lower success rate of Helicobacter pylori eradication therapy in Japan. Amer J Clin Nutr 2017; 106: 581-8.
28.
Płudowski P, Karczmarewicz E, Bayer M, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endok Pol 2017; 64: 319-27.
29.
Shafrir A, Shauly-Aharonov M, Katz LH, et al. The association between serum vitamin D levels and Helicobacter pylori presence and eradication. Nutrients 2021; 13: 278.
30.
Mut Surmeli D, Surmeli ZG, Bahsi R, et al. Vitamin D deficiency and risk of Helicobacter pylori infection in older adults: a cross-sectional study. Aging Clin Exp Res 2019; 31: 985-91.
31.
Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 2020; 74: 1498-513.
32.
El Shahawy MS, Hemida MH, El Metwaly I, Shady ZM. The effect of vitamin D deficiency on eradication rates of Helicobacter pylori infection. JGH Open 2018; 2: 270-5.
33.
Hu W, Zhang L, Li MX, et al. Vitamin D3 activates the autolysosomal degradation function against Helicobacter pylori through the PDIA3 receptor in gastric epithelial cells. Autophagy 2019; 15: 707-25.
34.
Salem-Sokhn E, Salami A, Fawaz M, et al. Helicobacter pylori interacts with serum vitamin D to influence hypertension. Cur Aging Sci 2021; 14: 26-31.
35.
Huang B, Yan S, Chen C, Ye S. Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes. Wien Klin Woch 2019; 131: 75-80.